{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T13:06:48Z","timestamp":1773752808138,"version":"3.50.1"},"reference-count":51,"publisher":"MDPI AG","issue":"5","license":[{"start":{"date-parts":[[2014,5,20]],"date-time":"2014-05-20T00:00:00Z","timestamp":1400544000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Cyclosporin A (CsA), a calcineurin inhibitor, remain the cornerstone of immunosuppressive regimens, regardless of nephrotoxicity, which depends on the duration of drug exposure. The mechanisms and biomarkers underlying the transition from CsA-induced renal dysfunction to nephrotoxicity deserve better elucidation, and would help clinical decisions. This study aimed to clarify these issues, using a rat model of short- and long-term CsA (5 mg\/kg bw\/day) treatments (3 and 9 weeks, respectively). Renal function was assessed on serum and urine; kidney tissue was used for histopathological characterization and gene and\/or protein expression of markers of proliferation, fibrosis and inflammation. In the short-term, creatinine and blood urea nitrogen (BUN) levels increased and clearances decreased, accompanied by glomerular filtration rate (GFR) reduction, but without kidney lesions; at that stage, CsA exposure induced proliferating cell nuclear antigen (PCNA), transforming growth factor beta 1 (TGF-\u03b21), factor nuclear kappa B (NF-\u03ba\u03b2) and Tumor Protein P53 (TP53) kidney mRNA up-regulation. In the long-term treatment, renal dysfunction data was accompanied by glomerular and tubulointerstitial lesions, with remarkable kidney mRNA up-regulation of the mammalian target of rapamycin (mTOR) and the antigen identified by monoclonal antibody Ki-67 (Mki67), accompanied by mTOR protein overexpression. Transition from CsA-induced renal dysfunction to nephrotoxicity is accompanied by modification of molecular mechanisms and biomarkers, being mTOR one of the key players for kidney lesion evolution, thus suggesting, by mean of molecular evidences, that early CsA replacement by mTOR inhibitors is indeed the better therapeutic choice to prevent chronic allograft nephropathy.<\/jats:p>","DOI":"10.3390\/ijms15058979","type":"journal-article","created":{"date-parts":[[2014,5,20]],"date-time":"2014-05-20T11:41:17Z","timestamp":1400586077000},"page":"8979-8997","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":32,"title":["Transition from Cyclosporine-Induced Renal Dysfunction to Nephrotoxicity in an in Vivo Rat Model"],"prefix":"10.3390","volume":"15","author":[{"given":"Jos\u00e9","family":"Sereno","sequence":"first","affiliation":[{"name":"Laboratory of Pharmacology & Experimental Therapeutics, Institute for Biomedical Imaging and Life Sciences (IBILI), Faculty of Medicine, University of Coimbra, Coimbra 3000-548, Portugal"},{"name":"Institute for Nuclear Sciences Applied to Health (ICNAS), University of Coimbra, Coimbra 3000-548, Portugal"}]},{"given":"Paulo","family":"Rodrigues-Santos","sequence":"additional","affiliation":[{"name":"Institute of Immunology, Faculty of Medicine, University of Coimbra, Coimbra 3004-504, Portugal"},{"name":"Immunology and Oncology Laboratory, Center for Neurosciences and Cell Biology, Coimbra 3004-504, Portugal"}]},{"given":"Helena","family":"Vala","sequence":"additional","affiliation":[{"name":"Agrarian School of Viseu (ESAV), Polytechnic Institute of Viseu, Viseu 3500-606, Portugal"},{"name":"Educational, Technologies and Health Study Center, Polytechnic Institute of Viseu, Viseu 3500-606, Portugal"}]},{"given":"Petronila","family":"Rocha-Pereira","sequence":"additional","affiliation":[{"name":"Research Center for Health Sciences, Beira Interior University, Covilh\u00e3 6201-506, Portugal"}]},{"given":"Rui","family":"Alves","sequence":"additional","affiliation":[{"name":"University Nephrology Unit, Faculty of Medicine, University of Coimbra, Coimbra 3004-504, Portugal"}]},{"given":"Jo\u00e3o","family":"Fernandes","sequence":"additional","affiliation":[{"name":"Laboratory of Pharmacology & Experimental Therapeutics, Institute for Biomedical Imaging and Life Sciences (IBILI), Faculty of Medicine, University of Coimbra, Coimbra 3000-548, Portugal"},{"name":"Biochemistry Department, Pharmacy Faculty, Porto University, Porto 4050-313, Portugal"}]},{"given":"Alice","family":"Santos-Silva","sequence":"additional","affiliation":[{"name":"Biochemistry Department, Pharmacy Faculty, Porto University, Porto 4050-313, Portugal"},{"name":"Institute for Molecular and Cellular Biology, Porto University, Porto 4150-180, Portugal"}]},{"given":"Eug\u00e9nia","family":"Carvalho","sequence":"additional","affiliation":[{"name":"Insulin Resistance & Adipocyte Group, Center for Neuroscience and Cell Biology, Coimbra 3004-504, Portugal"},{"name":"The Portuguese Diabetes Association (APDP), Lisbon 1250-203, Portugal"}]},{"given":"Frederico","family":"Teixeira","sequence":"additional","affiliation":[{"name":"Laboratory of Pharmacology & Experimental Therapeutics, Institute for Biomedical Imaging and Life Sciences (IBILI), Faculty of Medicine, University of Coimbra, Coimbra 3000-548, Portugal"}]},{"given":"Fl\u00e1vio","family":"Reis","sequence":"additional","affiliation":[{"name":"Laboratory of Pharmacology & Experimental Therapeutics, Institute for Biomedical Imaging and Life Sciences (IBILI), Faculty of Medicine, University of Coimbra, Coimbra 3000-548, Portugal"}]}],"member":"1968","published-online":{"date-parts":[[2014,5,20]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"2715","DOI":"10.1056\/NEJMra033540","article-title":"Immunosuppressive drugs for kidney transplantation","volume":"351","author":"Halloran","year":"2004","journal-title":"N. Engl. J. Med"},{"key":"ref_2","first-page":"493","article-title":"Cyclosporine in transplantation\u2014A history of converging timelines","volume":"25","author":"Colombo","year":"2011","journal-title":"J. Biol. Regul. Homeost. Agents"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"4965","DOI":"10.3390\/ijms15034965","article-title":"P-Glycoprotein and drug resistance in systemic autoimmune diseases","volume":"15","author":"Rosado","year":"2014","journal-title":"Int. J. Mol. Sci"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1186\/1479-5876-7-64","article-title":"Mycophenolate pharmacokinetics and pharmacodynamics in belatacept treated renal allograft recipients\u2014A pilot study","volume":"7","author":"Bremer","year":"2009","journal-title":"J. Transl. Med"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1111\/j.1600-6143.2011.03504.x","article-title":"Chronic calcineurin inhibitor nephrotoxicity-lest we forget","volume":"11","author":"Chapman","year":"2011","journal-title":"Am. J. Transplant"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1111\/j.1432-2277.2011.01242.x","article-title":"Hypertension in kidney transplant recipients","volume":"24","author":"Ponticelli","year":"2011","journal-title":"Transpl. Int"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1053\/jlts.2000.9737","article-title":"Posttransplantation hypertension related to calcineurin inhibitors","volume":"6","author":"Textor","year":"2000","journal-title":"Liver Transpl"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1001\/jama.283.5.633","article-title":"Arterial hypertension and renal allograft survival","volume":"283","author":"Mange","year":"2000","journal-title":"JAMA"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"234S","DOI":"10.1016\/j.transproceed.2004.01.011","article-title":"Nephrotoxic aspects of cyclosporine","volume":"36","author":"Cattaneo","year":"2004","journal-title":"Transplant. Proc"},{"key":"ref_10","first-page":"1","article-title":"Calcineurin inhibitor-free protocols: Risks and benefits","volume":"18","author":"Barbari","year":"2007","journal-title":"Saudi J. Kidney Dis. Transpl"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1517\/14656566.6.3.479","article-title":"Sirolimus: A new option in transplantation","volume":"6","author":"Mota","year":"2005","journal-title":"Expert Opin. Pharmacother"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1111\/j.1432-2277.2009.00858.x","article-title":"Practical recommendations for the early use of m-TOR inhibitors (sirolimus) in renal transplantation","volume":"22","author":"Campistol","year":"2009","journal-title":"Transpl. Int"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1093\/ndt\/gfh639","article-title":"Nephrotoxicity of rapamycin: An emerging problem in clinical medicine","volume":"20","author":"Marti","year":"2005","journal-title":"Nephrol. Dial. Transplant"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.transproceed.2005.12.023","article-title":"Conversion to sirolimus from cyclosporine may induce nephrotic proteinuria and progressive deterioration of renal function in chronic allograft nephropathy patients","volume":"38","author":"Banasik","year":"2006","journal-title":"Transplant. Proc"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.2165\/00002018-200629120-00006","article-title":"Sirolimus-associated proteinuria and renal dysfunction","volume":"29","author":"Rangan","year":"2006","journal-title":"Drug Saf"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1038\/nrneph.2009.94","article-title":"Transplantation: To convert or not to convert: Lessons from the CONVERT trial","volume":"5","author":"Bunnapradist","year":"2009","journal-title":"Nat. Rev. Nephrol"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.taap.2011.02.015","article-title":"Identification of novel indicators of cyclosporine A nephrotoxicity in a CD-1 mouse model","volume":"252","author":"Slattery","year":"2011","journal-title":"Toxicol. Appl. Pharmacol"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1159\/000349921","article-title":"Ginseng treatment attenuates chronic cyclosporine nephropathy via reducing oxidative stress in an experimental mouse model","volume":"37","author":"Doh","year":"2013","journal-title":"Am. J. Nephrol"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1159\/000114004","article-title":"Nigella sativa oil for prevention of chronic cyclosporine nephrotoxicity: An experimental model","volume":"28","author":"Uz","year":"2008","journal-title":"Am. J. Nephrol"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1159\/000345988","article-title":"Mechanisms of cyclosporine-induced renal cell apoptosis: A systematic review","volume":"37","author":"Xiao","year":"2013","journal-title":"Am. J. Nephrol"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1159\/000127432","article-title":"Prolonged endoplasmic reticulum stress induces apoptotic cell death in an experimental model of chronic cyclosporine nephropathy","volume":"28","author":"Han","year":"2008","journal-title":"Am. J. Nephrol"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"E255","DOI":"10.1016\/j.jss.2012.02.059","article-title":"Rapamycin is less fibrogenic than Cyclosporin A as demonstrated in a rat model of chronic allograft nephropathy","volume":"179","author":"Luo","year":"2013","journal-title":"J. Surg. Res"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.taap.2008.01.019","article-title":"Response of human renal tubular cells to cyclosporine and sirolimus: A toxicogenomic study","volume":"229","author":"Pallet","year":"2008","journal-title":"Toxicol. Appl. Pharmacol"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"F1281","DOI":"10.1152\/ajprenal.00188.2010","article-title":"TGF-\u03b21 mediates sirolimus and cyclosporine A-induced alteration of barrier function in renal epithelial cells via a noncanonical ERK1\/2 signaling pathway","volume":"301","author":"Slattery","year":"2011","journal-title":"Am. J. Physiol. Renal Physiol"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1093\/toxsci\/kfs108","article-title":"GSK3, snail, and adhesion molecule regulation by cyclosporine A in renal tubular cells","volume":"127","author":"Berzal","year":"2012","journal-title":"Toxicol. Sci"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1146\/annurev.pharmtox.41.1.347","article-title":"Use of biomarkers and surrogate endpoints in drug development and regulatory decision making: criteria, validation, strategies","volume":"41","author":"Lesko","year":"2001","journal-title":"Ann. Rev. Pharmacol. Toxicol"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/1479-5876-5-47","article-title":"Diagnosis of drug-induced renal tubular toxicity using global gene expression profiles","volume":"5","author":"Jiang","year":"2007","journal-title":"J. Transl. Med"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/j.transproceed.2013.02.085","article-title":"Serum and renal tissue markers of nephropathy in rats under immunosuppressive therapy: Cyclosporine vs. sirolimus","volume":"45","author":"Sereno","year":"2013","journal-title":"Transplant. Proc"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.2215\/CJN.03820609","article-title":"Chronic calcineurin inhibitor nephrotoxicity: Reflections on an evolving paradigm","volume":"4","author":"Gaston","year":"2009","journal-title":"Clin. J. Am. Soc. Nephrol"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1038\/ki.2010.93","article-title":"The unsolved cyclosporine-induced kidney injury: Is paricalcitol a feasible new renoprotective option?","volume":"77","author":"Reis","year":"2010","journal-title":"Kidney Int"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1002\/jlb.57.4.536","article-title":"NFATp, a cyclosporin-sensitive transcription factor implicated in cytokine gene induction","volume":"57","author":"Rao","year":"1995","journal-title":"J. Leukoc. Biol"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/ni1429","article-title":"T cell-directed therapies: Lessons learned and future prospects","volume":"8","author":"Liu","year":"2007","journal-title":"Nat. Immunol"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1111\/j.1582-4934.2009.00910.x","article-title":"Calcineurin A-\u03b2 is required for hypertrophy but not matrix expansion in the diabetic kidney","volume":"15","author":"Reddy","year":"2011","journal-title":"J. Cell. Mol. Med"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1242\/dmm.003533","article-title":"Recipient toll-like receptors contribute to chronic graft dysfunction by both MyD88- and TRIF-dependent signaling","volume":"3","author":"Wang","year":"2010","journal-title":"Dis. Model. Mech"},{"key":"ref_35","first-page":"636","article-title":"Accelerated renal disease is associated with the development of metabolic syndrome in a glucolipotoxic mouse model","volume":"5","author":"Izquierdo","year":"2012","journal-title":"Dis. Model. Mech"},{"key":"ref_36","first-page":"627","article-title":"High-fat-diet-induced obesity causes an inflammatory and tumor-promoting microenvironment in the rat kidney","volume":"5","author":"Stemmer","year":"2012","journal-title":"Dis. Model. Mech"},{"key":"ref_37","first-page":"238","article-title":"Increased urinary lipoperoxide levels in renal transplant patients","volume":"19","author":"Knight","year":"1989","journal-title":"Ann. Clin. Lab. Sci"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0022-3565(24)39205-5","article-title":"Oxidative stress induced by tert-butyl hydroperoxide causes vasoconstriction in the aorta from hypertensive and aged rats: Role of cyclooxygenase-2 isoform","volume":"293","author":"Marin","year":"2000","journal-title":"J. Pharmacol. Exp. Ther"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/nbt.1622","article-title":"Urinary clusterin, cystatin C, \u03b22-microglobulin and total protein as markers to detect drug-induced kidney injury","volume":"28","author":"Dieterle","year":"2010","journal-title":"Nat. Biotechnol"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"481","DOI":"10.2215\/CJN.04800908","article-title":"Calcineurin inhibitor nephrotoxicity","volume":"4","author":"Naesens","year":"2009","journal-title":"Clin. J. Am. Soc. Nephrol"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1038\/nrneph.2009.113","article-title":"The pathogenesis and treatment of chronic allograft nephropathy","volume":"5","author":"Li","year":"2009","journal-title":"Nat. Rev. Nephrol"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1038\/ki.2010.69","article-title":"Paricalcitol attenuates cyclosporine-induced kidney injury in rats","volume":"77","author":"Park","year":"2010","journal-title":"Kidney Int"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"8204","DOI":"10.1073\/pnas.0502857102","article-title":"The coordinate regulation of the p53 and mTOR pathways in cells","volume":"102","author":"Feng","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.cell.2012.03.017","article-title":"mTOR signaling in growth control and disease","volume":"149","author":"Laplante","year":"2012","journal-title":"Cell"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1681\/ASN.2008111186","article-title":"The role of the mammalian target of rapamycin (mTOR) in renal disease","volume":"20","author":"Lieberthal","year":"2009","journal-title":"J. Am. Soc. Nephrol"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"F440","DOI":"10.1152\/ajprenal.00379.2007","article-title":"Low-dose mTOR inhibition by rapamycin attenuates progression in anti-thy1-induced chronic glomerulosclerosis of the rat","volume":"294","author":"Scholl","year":"2008","journal-title":"Am. J. Physiol. Renal Physiol"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"e33626","DOI":"10.1371\/journal.pone.0033626","article-title":"Rapamycin ameliorates kidney fibrosis by inhibiting the activation of mTOR signaling in interstitial macrophages and myofibroblasts","volume":"7","author":"Chen","year":"2012","journal-title":"PLoS One"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.vascn.2007.03.001","article-title":"Measurement of glomerular filtration rate in the conscious rat","volume":"56","author":"Pestel","year":"2007","journal-title":"J. Pharmacol. Toxicol. Methods"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s12012-009-9054-2","article-title":"Erythropoietin promotes deleterious cardiovascular effects and live risk in a rat model of chronic sports doping","volume":"9","author":"Piloto","year":"2009","journal-title":"Cardiovasc. Toxicol"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"RESEARCH0034","DOI":"10.1186\/gb-2002-3-7-research0034","article-title":"Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes","volume":"3","author":"Vandesompele","year":"2002","journal-title":"Genome Biol"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2\u2212\u0394\u0394Ct method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/15\/5\/8979\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T21:11:35Z","timestamp":1760217095000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/15\/5\/8979"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,5,20]]},"references-count":51,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2014,5]]}},"alternative-id":["ijms15058979"],"URL":"https:\/\/doi.org\/10.3390\/ijms15058979","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,5,20]]}}}